Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

Alessandro Ottaiano,Anna Nappi,Salvatore Tafuto,Guglielmo Nasti,Chiara De Divitiis,Carmela Romano,Antonino Cassata,R. Casaretti,Lucrezia Silvestro,Antonio Avallone,Maurizio Capuozzo,Monica Capozzi,Piera Maiolino,Vincenzo Quagliariello,Stefania Scala,Vincenzo Rosario Iaffaioli

Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy

2016

Alessandro Ottaiano
Anna Nappi
Salvatore Tafuto
Guglielmo Nasti
Chiara De Divitiis
Carmela Romano
Antonino Cassata
R. Casaretti
Lucrezia Silvestro
Antonio Avallone
Maurizio Capuozzo
Monica Capozzi
Piera Maiolino
Vincenzo Quagliariello
Stefania Scala
Vincenzo Rosario Iaffaioli

Background: There are few background data on the impact of clinical factors on neurotoxicity and prognosis in patients treated with adjuvant capecitabine and oxal

Keywords:

Capecitabine
Medicine
Neurotoxicity
Colorectal cancer
Body mass index
Adjuvant
Oxaliplatin
Chemotherapy
Oncology
Internal medicine
Diabetes mellitus
adjuvant chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations